ContraFect Corp

Company Profile

ContraFect Corp had its IPO on 2014-07-29 under the ticker symbol CFRX.

The company operates in the Healthcare sector and Biotechnology industry. ContraFect Corp has a staff strength of 38 employees.

Stock update

Shares of ContraFect Corp opened at $2.29 at the start of the last trading session i.e. 2023-03-30.

The stocks traded within a range of $2.12 - $2.43, and closed at $2.19.

This is a -4.37% slip from the previous day's closing price.

A total volume of 41,278 shares were traded at the close of the day’s session.

In the last one week, shares of ContraFect Corp have increased by +10.05%.

ContraFect Corp's Key Ratios

ContraFect Corp has a market cap of $2.84 million, indicating a price to book ratio of 0.4405 and a price to sales ratio of 0.

In the last 12-months ContraFect Corp’s revenue was $0 with a gross profit of $-1606434 and an EBITDA of $-64113000. The EBITDA ratio measures ContraFect Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, ContraFect Corp’s operating margin was 0% while its return on assets stood at -79.64% with a return of equity of -239.32%.

In Q3, ContraFect Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

ContraFect Corp’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-126.49 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into ContraFect Corp’s profitability.

ContraFect Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0.163. Its price to sales ratio in the trailing 12-months stood at 0.

ContraFect Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$23.03 million

Total Liabilities

$23.78 million

Operating Cash Flow

$4.77 million

Capital Expenditure

$19000

Dividend Payout Ratio

0%

ContraFect Corp ended 2023 with $23.03 million in total assets and $0 in total liabilities. Its intangible assets were valued at $23.03 million while shareholder equity stood at $-3103000.00.

ContraFect Corp ended 2023 with $0 in deferred long-term liabilities, $23.78 million in other current liabilities, 4000.00 in common stock, $-315865000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $4.66 million and cash and short-term investments were $17.65 million. The company’s total short-term debt was $667,000 while long-term debt stood at $0.

ContraFect Corp’s total current assets stands at $20.05 million while long-term investments were $0 and short-term investments were $12.98 million. Its net receivables were $586000.00 compared to accounts payable of $15.35 million and inventory worth $0.

In 2023, ContraFect Corp's operating cash flow was $4.77 million while its capital expenditure stood at $19000.

Comparatively, ContraFect Corp paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$2.19

52-Week High

$363.2

52-Week Low

$1.75

Analyst Target Price

$3.67

ContraFect Corp stock is currently trading at $2.19 per share. It touched a 52-week high of $363.2 and a 52-week low of $363.2. Analysts tracking the stock have a 12-month average target price of $3.67.

Its 50-day moving average was $4.02 and 200-day moving average was $36.03 The short ratio stood at 0.04 indicating a short percent outstanding of 0%.

Around 204.7% of the company’s stock are held by insiders while 1214.7% are held by institutions.